Rox Medical Inc. Announces First Clinical Use of the ROX FLO2W Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients
10/31/2011 9:03:30 AM
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--ROX Medical, Inc., a world leader in the development of unique minimally invasive medical devices for the treatment of advanced COPD and resistant hypertension, today announced the first clinical use of the ROX CO2UPLERTM at the Universitair Ziekenhuis Brussel (University Hospital of Brussels) to treat resistant hypertension. Resistant hypertension is defined as blood pressure that remains above an optimal goal despite the concomitant use of antihypertensive medications from three or more classes.
comments powered by